AIM

AIM ImmunoTech Inc
AMEX

Real-time Quotes | Nasdaq Last Sale

2.090
+0.030
+1.46%
After Hours: 2.080 -0.01 -0.48% 19:33 09/18 EDT
OPEN
1.980
PREV CLOSE
2.060
HIGH
2.090
LOW
1.980
VOLUME
1.16M
TURNOVER
--
52 WEEK HIGH
7.11
52 WEEK LOW
0.3810
MARKET CAP
82.95M
P/E (TTM)
-1.4016
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average AIM stock price target is 6.25 with a high estimate of 7.25 and a low estimate of 5.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About AIM
AIM ImmunoTech Inc., formerly Hemispherx Biopharma, Inc., is a specialty pharmaceutical company. The Company is engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. The Company's segment is engaged in research and development activities related to Ampligen and other drugs under development, and sales and marketing of Alferon. The Company's products include Alferon N Injection and Ampligen. Alferon N Injection is approved for the use in intralesional treatment of refractory or recurring external genital warts in patients of over 18 years of age. Ampligen is a drug undergoing clinical development for the treatment of Chronic Fatigue Syndrome (CFS). Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) is a low-dose, oral liquid formulation of natural alpha interferon. Alferon LDO is a liquid natural interferon for oral administration.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of AIM ImmunoTech Inc stock information, including AMEX:AIM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AIM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AIM stock methods without spending real money on the virtual paper trading platform.